Whilst reduced-rely MBL not often progresses to CLL, high-count MBL progresses to CLL necessitating therapy at a amount of 1% to two% per annum. Large-count MBL is distinguished from Rai 0 CLL according to whether the B-cell depend is higher than or down below five × 109/L. While people today with both high-rely MBL and CLL Rai phase 0 are at incr